Literature DB >> 6340675

Antagonists of the luteinizing hormone releasing hormone with pyridyl-alanines which completely inhibit ovulation at nanogram dosage.

K Folkers, C Y Bowers, T Kubiak, J Stepinski.   

Abstract

[N-Ac-D-2-Nal1,pCl-D-Phe2,D-3-Pal3,D-Arg6,D-Ala10]-LHRH caused 100% and 57% inhibition of ovulation in rats, s.c., at 500 and 250 ng, respectively, and 56%, per os at 500 micrograms. [N-Ac-3,4-diC1-D-Phe1,pC1-D-Phe2,D-3-Pal3,D-Arg6,D-Ala10]-LHRH inhibited ovulation, s.c., 82% at 500 ng, and 63%, per os at 500 micrograms. These analogs are the most effective reported inhibitors of ovulation. The new introduction of pyridyl-alanines can be superior substituents. For pairs of analogs, relationships are: D-3-Pal (beta-(3-pyridyl)-D-alpha-alanine) in position 3 is superior to D-Trp3, D-2-Pal3 and D-4-Pal3. D-Arg6 was superior to D-3-Pal6 and D-4-Pal6 was superior by 2-fold to D-Arg6. D-Ala10 was superior to Gly10 and D-Abu10.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340675     DOI: 10.1016/0006-291x(83)91411-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Disposition of detirelix, a potent luteinizing hormone-releasing hormone antagonist, in rats and monkeys.

Authors:  R L Chan; W Ho; A S Webb; J A LaFargue; C A Nerenberg
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

2.  Decapeptides as effective agonists from L-amino acids biologically equivalent to the luteinizing hormone-releasing hormone.

Authors:  K Folkers; C Y Bowers; P F Tang; M Kubota
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Chirospecific synthesis of D and Lp-chlorohomophenylalanine N-t-BOC DCHA salts.

Authors:  J W Cessac; P N Rao; H K Kim
Journal:  Amino Acids       Date:  1994-02       Impact factor: 3.520

4.  A practical and scalable system for heteroaryl amino acid synthesis.

Authors:  R A Aycock; D B Vogt; N T Jui
Journal:  Chem Sci       Date:  2017-10-02       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.